QBiotics Group
QBiotics Investor Overview : Game-Changing Pharmaceuticals
Cancer is responsible for one in six deaths, making it the second most common cause of death globally.
Surgery, radiotherapy, chemotherapy and immunotherapies for cancer have varying degrees of success, side effects and recovery; and they are often very expensive.
There is a compelling need for a non-invasive treatment which targets and kills only the tumour, and ideally any secondary tumours, with minimal/no systemic side effects; at a lower cost.
QBiotics’ outstanding advantages :
The game-changing anti-cancer compound, tigilanol tiglate, injected directly into solid tumours is disrupting the treatment of various cancers. Its unique mode of action completely destroys the tumour and promotes rapid and complete healing of the site, often after one injection. It has been launched for Veterinary use in the USA, Europe (27 countries) and Australia). Numerous clinical trials are in progress for various cancers in humans.
A unique wound healing agent, EBC-1013, has a novel mode of action combining antimicrobial activity, biofilm disruption and immune system stimulation for both human and veterinary use. Chronic wounds impact tens of millions of people globally and cost billions of dollars pa.
The simultaneous human/veterinary development model delivers earlier, greater returns.
Proprietary drug discovery technology EcoLogic™ identifies next-generation antibiotics and anti-inflammatories, expanding the product portfolio and providing future growth opportunities.
World-class Board and Leadership Team to take the company public and to becoming one of Australia’s foremost healthcare successes. They have a proven track record of growing and listing global companies which have very significant market capitalisations.
Predicted to be 'one of the country’s healthcare success stories; in the same vein as CSL, Cochlear and ResMed.'
$85m raised in 2021 provides a 3-year runway to achieve key milestones.
Clear exit strategy through an IPO and listing on the stock exchange.
The only way to acquire QBiotics shares is through private, off-market share sales.
Parcels of shares are available for purchase through Achieve Capital Pty Limited. Min. purchase is $5,000 worth of shares. Contact steve.hobbs@achievecapital.com.au
Background & History
Proin auctor bibendum ex, non condimentum tortor sodales vitae. Ut feugiat at lorem accumsan consequat.
Suspendisse ac condimentum ipsum, sit amet auctor dui. Aliquam pretium justo in commodo varius.
Pellentesque elementum felis non urna vulputate, non posuere metus suscipit.
Aenean lacinia id quam a lobortis. Cras nibh lorem, vulputate eget purus elementum, pharetra condimentum elit.
Quisque et sagittis ex, vitae ultrices nulla. Vivamus dapibus blandit libero, et scelerisque dui ullamcorper ut. Vivamus ut molestie ex. Integer eget tempus mauris. Quisque volutpat pulvinar urna, posuere pharetra ex auctor vel. Sed id lacus tortor. Proin nisl turpis, tempus a leo in, lacinia volutpat orci.
Aenean nulla nibh, porta a dignissim vitae, laoreet vitae lacus. Nunc in aliquet urna. Vivamus vel turpis a mi consequat venenatis. Pellentesque tincidunt ante ut urna accumsan lacinia. Sed sed enim volutpat, malesuada metus ut, lobortis lectus. Sed vulputate fringilla justo, sed condimentum tellus fermentum sit amet. Pellentesque tempus elit id dapibus ornare. Phasellus accumsan suscipit elit. Donec eget libero eget neque cursus bibendum. Praesent lacinia felis et aliquam condimentum. Proin vestibulum posuere tortor at finibus. Etiam posuere neque eu elit sollicitudin sollicitudin. Sed viverra ante eros, et maximus tortor viverra et.
Quisque a nunc maximus, eleifend est eget, mattis mauris. Aliquam non eleif
Open an account to get
access to more details
Key Achievement & Milestones
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque. Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.
Proin neque lacus, semper vel ex at, eleifend rhoncus est.
Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a.
Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam vulputate enim velit, eu pretium justo tristique ac.
Nam vitae varius augue. Nam pharetra facilisis elementum. Sed nisl risus, vestibulum ut velit at, dapibus sagittis arcu.
Nullam sed dolor suscipit, efficitur enim quis, vestibulum sapien. Nunc convallis mauris nec nibh mollis, eget aliquet odio tincidunt.
Phasellus faucibus sem mauris, sed iaculis nisl egestas sed.
Sed sit amet gravida elit, sagittis sollicitudin nulla. Vivamus auctor arcu eu scelerisque convallis. Phasellus scelerisque ultrices tincidunt. Curabitur odio libero, faucibus et felis nec, pulvinar facilisis urna. Interdum et malesuada fames ac ante ipsum primis in faucibus. Maecenas ultrices in velit at ultrices.
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet. Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim.
In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum velit. Praesent rh
Open an account to get
access to more details
Board & Management
Cras eleifend purus vitae mattis imperdiet.
Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.
Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.
Fusce scelerisque massa sit amet turpis rutrum semper.
Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.
Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.
Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat
Open an account to get
access to more details
Investment Highlights
Cras eleifend purus vitae mattis imperdiet.
Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.
Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.
Fusce scelerisque massa sit amet turpis rutrum semper.
Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.
Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.
Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat auctor mattis. Sed quis consectetur ma
Open an account to get
access to more details
See more exiting opportunities on CapitalHQ
Backed By Leading Investment Groups and Family Offices
